Nephoros Pharma Sources Private Limited - Company Profile

It is a chemicals private limited company based in Indore, Madhya Pradesh, India, established in 2010.
2010 Indore, Madhya Pradesh, India Struck Off
Last Updated:
About Nephoros Pharma Sources Private Limited

Nephoros Pharma Sources Private Limited, a struck off private limited company, was established on 09 February 2010 in Indore, Madhya Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230MP2010PTC023043. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shree Bhagwan Agarwal (Director), Shalini Jain (Director), Arvind Kumar Kankane (Director). It is based at 15 / 13/ 3, South Tukoganj,, Indore, Madhya Pradesh, 452001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MP2010PTC023043

  • Registration Number

    023043

  • Incorporation Date

    09 February 2010

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 1 Day
Company report

Nephoros Pharma Sources Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nephoros Pharma Sources Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Nephoros Pharma Sources Private Limited?
Current Directors
Name Designation Appointment Date Status
Shree Bhagwan Agarwal Director 09 Feb 2010 Current
Shalini Jain Director 09 Feb 2010 Current
Arvind Kumar Kankane Director 09 Feb 2010 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nephoros Pharma Sources.

Enhance accessibility to Nephoros Pharma Sources's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Nephoros Pharma Sources revenue growth over time
Nephoros Pharma Sources profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nephoros Pharma Sources?

Unlock access to Nephoros Pharma Sources's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nephoros Pharma Sources?

Unlock and access historical data on people associated with Nephoros Pharma Sources, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nephoros Pharma Sources, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nephoros Pharma Sources's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nephoros Pharma Sources
Recent Activity within the Organization
  • Director Appointment

    Shree Bhagwan Agarwal was appointed as a Director was appointed as a Director on 09 Feb 2010 & has been associated with this company since 16 years 1 day . was recorded as a recent event.

  • Director Appointment

    The activity Shalini Jain was appointed as a Director was appointed as a Director on 09 Feb 2010 & has been associated with this company since 16 years 1 day . was completed.

  • Director Appointment

    Progress on Arvind Kumar Kankane was appointed as a Director was appointed as a Director on 09 Feb 2010 & has been associated with this company since 16 years 1 day . was documented.

  • Company Incorporation

    Progress on Nephoros Pharma Sources Private Limited was registered on 09 Feb 2010 with Roc Gwalior & aged 16 years 1 day as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nephoros Pharma Sources Private Limited?

The CIN of Nephoros Pharma Sources Private Limited is U24230MP2010PTC023043.

Where is Nephoros Pharma Sources Private Limited headquartered?

Nephoros Pharma Sources Private Limited is headquartered at 15 / 13/ 3, South Tukoganj,, Indore, Madhya Pradesh, 452001.

When was Nephoros Pharma Sources Private Limited incorporated?

Nephoros Pharma Sources Private Limited was incorporated on 09 February 2010.

Who are the current directors of Nephoros Pharma Sources Private Limited?

The current directors of Nephoros Pharma Sources Private Limited are

What is the primary industry of Nephoros Pharma Sources Private Limited?

The primary industry of Nephoros Pharma Sources Private Limited is Chemicals.

Is Nephoros Pharma Sources Private Limited a listed company?

Nephoros Pharma Sources Private Limited is unlisted.

What is the capital structure of Nephoros Pharma Sources Private Limited?

The authorized capital of Nephoros Pharma Sources Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available